Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Tetra Bio-Pharma Inc T.TBP

Alternate Symbol(s):  TBPMF | T.TBP.W.B | T.TBP.W.C

Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: TSX touches 9-week peak
Weaker-than-expected Chinese data revived fears about a global economic slowdown on Monday, putting a dent in oil prices and sending energy stocks tumbling. Canada’s main stock index fell from its... read article.

RE:RE:Tetra is broke and Reduvo will not save the scamming CEO

Deficit 140,000,000  yes or no ?  and yes it will take another 500,000,000 for Qixleef to be anything for years , they are not done Phase 2 , still Phase 3, Phase 4 then review and more

Global Leader in 3D Geospatial Data & Intelligence Solutions Announces 100% Quarterly Revenue Growth

Intermap Technologies announced that second quarter and first half revenue rose more than 100% over 2021. For the quarter and six months ending June 30, 2022, the Company reported revenue of $2.4 million and $4.4 million, compared with $1.2 million and $2.1 million, respectively, for the same periods last year. Government sales improved to $1.7 million compared with $0.2 million for the prior year more

RE:Tetra is broke and Reduvo will not save the scamming CEO

spreading half truths as usual...the company does not owe 140m...those are accumulated losses. FOOL.  $500mil to take it over finish line another lie. but it will take a few million. wrong more

RE:RE:RE:Total funds raised in trenches

The funds can't grant you a DIN or an approval, you are talking like its sure DIN will be granted this year, the same way every time to fool people,   rate and reply

Once again saying Revenue before end of year SCAMMER !

Here we go again any day now , you know nothing , you are once again exaggerating to suck people into this SCAM , you think borrowing and dilluting the company is so fantastic . Stop trying to more

RE:RE:Total funds raised in trenches

The funds are good enough to pass us Reduvo DIN and QIXLEEF phase II reborn trial. So we see some Reduvo revenue beofore the end of the year. It might be able to start ARD 003 Phase 1 trial not more

RE:Total funds raised in trenches

It wont be enough, because Guy Chamberland is earning his life with this, milky cow company !  rate and reply

RE:RE:Total funds raised in trenches

Not a single promise was kept !  rate and reply

Thematica Insights Report & Investor Guide

Thematica Report: Exploring the opportunities in battery metals

The Market Herald launches Thematica’s latest report: Battery Metals. Understand how battery metals are driving the future. Download today!

RE:Total funds raised in trenches

TBP's promising product pipeline, patents, talented management, durable partnerships and access to funds are all the markers of a successful biotech company.  $$$  rate and reply

Total funds raised in trenches

7.5 millions from Australian partnership  4.5 millions from government of Quebec  6.0 millions from this total 18 millions  burn rate 1 million per month. This should take us for more
@ the Bell: TSX up at the end of the week on broad gains
The major deal between Canada’s two main telecom companies, Rogers and Shaw, made progress on Friday, helping the TSX close higher in a broad increase across sectors. Gains were capped on concerns... read article.


ABO are vermin. They short the stock down and use the debentures to cover their shorts. Nothing more than a short side hedge fund.  rate and reply

6,000,000 at 10% =more costs = zero revenue = wages

Only 146,000,000 in the red now , I guess that is what you do when no one wants to invest in your dreams , you borrow more .  rate and reply


The market is ignoring all the noise coming from Guy Chamberland and TBP ,one thing matter REVENUE !  rate and reply


Good job. Not bad at all. It is hard to believe that Guy coming up with these deals. The last one with the Australian partnership and this one is really an improvement considering all the bad deals more


  Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean by @newswire on 11 Aug 2022, 22:19      OTTAWA, ON, Aug. 11, 2022 /CNW/ more

New Press Release - Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

OTTAWA, ON, Aug. 11, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that it has entered into a subscription agreement (the "Subscription Agreement") article.
Buzz on the Bullboards: Defying market expectations
Most market reviews are throwing around the dreaded R-word, “recession” like it’s going out of style. Once again, news headlines indicate that the markets may be steering towards one. It turns out... read article.

Over acting

U ever watch a movie where the actor over acts the part so bad he's not believable? There's an entourage of them here. U folks have been taking lessons out of the Alex Jones playbook. Maybe more

RE:Positive ARD003 results

Looks like orally taken cannabinoids products are going to be taking over.  $$$ more

RE:Positive ARD003 results

Google sepsis there are companies with Phase 3 trials happening as we speak , Guys research is 5 years behind , HE IS BUYING HIMSELF A WAGE, LOOKING BUSY , ARE THE RESULTS FROM THE FDA ? NO ARE more

RS is coming

We all know whats coming after a press release  rate and reply

Nice bit of news

Too bad it is not for the drug we all want to hear about. Maybe the next one will be  rate and reply